99898-73-4

Upstream product

• 57999-06-1 4-phenyl-1H-pyrazol-5-amine 
• 5591-70-8 4-phenyl-1H-pyrazol-3-ylamine 
• 117411-51-5 N-carbethoxy-N¹-(4-phenyl)pyrazol-3-yl-thiourea 
• 99898-70-1 8-phenyl-2-thioxo-2,3-dihydropyrazolo[1,5-a][1,3,5]triazin-4(1H)-one 
• 74-88-4 methyl iodide 

Downstream Products

• 99898-74-5 2-methylthio-4-chloro-8-phenylpyrazolo<1,5-a>-s-triazine 
• 99898-79-0 4-n-butylamino-8-phenylpyrazolo<1,5-a>-s-triazine 
• 99898-77-8 2-methylthio-4-n-butylamino-8-phenylpyrazolo<1,5-a>-s-triazine 

Relevant academic research and scientific papers

Microwave-assisted sequential one-pot synthesis of 8-substituted pyrazolo[1,5-a][1,3,5]triazines

This paper reports a convenient sequential one-pot approach for the synthesis of an array of 14 pyrazolo[1,5-a][1,3,5]triazines, substituted in C8 by halogen (Br), various functions (CN and CO2Et)2 and alkyl or (het)aryl groups. This study conf

Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action

Despite the availability of hundreds of antibiotic drugs, infectious diseases continue to remain one of the most notorious health issues. In addition, the disparity between the spread of multidrug-resistant pathogens and the development of novel classes of antibiotics exemplify an important unmet medical need that can only be addressed by identifying novel targets. Herein we demonstrate, by the development of the first in vivo active DegS inhibitors based on a pyrazolo[1,5-a]-1,3,5-triazine scaffold, that the serine protease DegS and the cell envelope stress-response pathway σE represent a target for generating antibiotics with a novel mode of action. Moreover, DegS inhibition is synergistic with well-established membrane-perturbing antibiotics, thereby opening promising avenues for rational antibiotic drug design.